APA (7th ed.) Citation

M, J., N, K., BJ, M., K, M., S, S., Y, S., . . . M, S. (2025). Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study. Cureus, 17(12), e100251. https://doi.org/10.7759/cureus.100251

Chicago Style (17th ed.) Citation

M, Joyce, et al. "Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study." Cureus 17, no. 12 (2025): e100251. https://doi.org/10.7759/cureus.100251.

MLA (9th ed.) Citation

M, Joyce, et al. "Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study." Cureus, vol. 17, no. 12, 2025, p. e100251, https://doi.org/10.7759/cureus.100251.